Navigation Links
David Cheresh receives top award for cancer metastasis research
Date:9/23/2010

David A. Cheresh, PhD, professor of pathology at the University of California, San Diego School of Medicine and associate director for translational research at the Moores UCSD Cancer Center, has been named the 2010 recipient of the Paget-Ewing Award, the highest prize bestowed by the Metastasis Research Society, an international, non-profit organization that promotes scientific research involving metastasis.

Cheresh was honored at a recent joint meeting of the MRS and the American Association for Cancer Research in Philadelphia.

Cheresh is the 10th recipient of the Paget-Ewing Award, which specifically celebrates scientific excellence and contributions to the understanding and control of cancer metastasis. The award is named after two pioneers in cancer research: Stephen Paget, an English surgeon who proposed the "seed and soil" theory of metastasis in 1899 and James Ewing, an American pathologist who significantly advanced understanding of how anatomical location and surrounding vascular systems affect tumors.

In recent research, Cheresh and colleagues identified a key microRNA molecule that controls a molecular switch governing blood vessel growth. Uncontrolled growth of blood vessels is a major problem in a broad range of diseases and conditions, including metastasizing or spreading tumors. The National Cancer Institute estimates as many as 500 million people worldwide could benefit from therapies controlling blood vessel growth, known as angiogenesis.

"I am very honored to receive this award, which has been given to some of the top people in the field," said Cheresh. "By better understanding metastasis, we can understand why most patients die from cancer. It's the spreading of the disease, not the primary tumor, that's the typical cause of mortality.

If we can learn how cancer works and thrives at the molecular level, we can find new ways to influence and perhaps halt the progression of the disease."

As part of the award ceremonies, Cheresh also gave a lecture to more than 700 attending cancer scientists on the subject of microRNA-mediated regulation of the tumor angiogenic switch.


'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California -- San Diego
Source:Eurekalert

Related medicine news :

1. Chopra Center Co-Founder and Mind-body Healing Pioneer David Simon, M.D. Diagnosed with Brain Tumor
2. Phoenix DUI Lawyer, David Michael Cantor, Speaks to The Young Adult Forum
3. Complicated Surgeries Carry Greater Risks, Possible Need for New York Medical Malpractice Attorneys According To David Perecman
4. New York Construction Accident Attorney, David Perecman, Supports MTA Night Work
5. David Hofer Named President of International Bancard Corporation
6. New York Personal Injury Lawyer, David Perecman, says New Playground is No Place for Kids
7. Chinatown Fire is Caused by Negligence, New York Personal Injury Attorney, David Perecman, Believes
8. David Perecman Comments On Bus Driver Assaulting Supervisor In New York
9. Dr. David Blyweiss Announces New IBS Relief Protocol
10. Exploring the Davids and Goliaths of therapeutic molecules
11. AMERICAN IDOL's David Cook Travels to Ethiopia with the UN Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology: